nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Hydrochlorothiazide—nephrolithiasis	0.257	1	CrCtD
Methyclothiazide—Thiazides—Hydrochlorothiazide—nephrolithiasis	0.216	0.635	CiPCiCtD
Methyclothiazide—Increased Diuresis—Hydrochlorothiazide—nephrolithiasis	0.124	0.365	CiPCiCtD
Methyclothiazide—SLC12A3—Hydrochlorothiazide—nephrolithiasis	0.0575	0.362	CbGbCtD
Methyclothiazide—CA1—Hydrochlorothiazide—nephrolithiasis	0.0361	0.228	CbGbCtD
Methyclothiazide—CA4—Hydrochlorothiazide—nephrolithiasis	0.034	0.214	CbGbCtD
Methyclothiazide—Diclofenamide—Hydrochlorothiazide—nephrolithiasis	0.0332	0.186	CrCrCtD
Methyclothiazide—CA2—Hydrochlorothiazide—nephrolithiasis	0.0312	0.197	CbGbCtD
Methyclothiazide—Hydroflumethiazide—Hydrochlorothiazide—nephrolithiasis	0.0254	0.142	CrCrCtD
Methyclothiazide—Cyclothiazide—Hydrochlorothiazide—nephrolithiasis	0.0208	0.116	CrCrCtD
Methyclothiazide—Polythiazide—Hydrochlorothiazide—nephrolithiasis	0.0208	0.116	CrCrCtD
Methyclothiazide—Benzthiazide—Hydrochlorothiazide—nephrolithiasis	0.0208	0.116	CrCrCtD
Methyclothiazide—Quinethazone—Hydrochlorothiazide—nephrolithiasis	0.0208	0.116	CrCrCtD
Methyclothiazide—Trichlormethiazide—Hydrochlorothiazide—nephrolithiasis	0.0191	0.107	CrCrCtD
Methyclothiazide—Chlorothiazide—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0991	CrCrCtD
Methyclothiazide—SLC12A3—loop of Henle—nephrolithiasis	0.00597	0.243	CbGeAlD
Methyclothiazide—SLC12A1—loop of Henle—nephrolithiasis	0.00456	0.186	CbGeAlD
Methyclothiazide—SLC12A3—collecting duct of renal tubule—nephrolithiasis	0.00339	0.138	CbGeAlD
Methyclothiazide—SLC12A1—collecting duct of renal tubule—nephrolithiasis	0.00259	0.106	CbGeAlD
Methyclothiazide—Xanthopsia—Hydrochlorothiazide—nephrolithiasis	0.00226	0.102	CcSEcCtD
Methyclothiazide—Angiitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.00226	0.102	CcSEcCtD
Methyclothiazide—Vasculitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.00197	0.0886	CcSEcCtD
Methyclothiazide—Sialoadenitis—Hydrochlorothiazide—nephrolithiasis	0.00169	0.076	CcSEcCtD
Methyclothiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00166	0.0911	CbGpPWpGaD
Methyclothiazide—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00159	0.0874	CbGpPWpGaD
Methyclothiazide—Cutaneous vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0711	CcSEcCtD
Methyclothiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00153	0.0837	CbGpPWpGaD
Methyclothiazide—SLC12A3—nephron—nephrolithiasis	0.00151	0.0615	CbGeAlD
Methyclothiazide—CA2—collecting duct of renal tubule—nephrolithiasis	0.00115	0.0471	CbGeAlD
Methyclothiazide—SLC12A1—nephron—nephrolithiasis	0.00115	0.047	CbGeAlD
Methyclothiazide—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0479	CcSEcCtD
Methyclothiazide—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.000988	0.0444	CcSEcCtD
Methyclothiazide—SLC12A1—urine—nephrolithiasis	0.000924	0.0377	CbGeAlD
Methyclothiazide—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.000785	0.0353	CcSEcCtD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.000701	0.0384	CbGpPWpGaD
Methyclothiazide—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.000649	0.0292	CcSEcCtD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.000641	0.0352	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.000641	0.0352	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.000637	0.0349	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.000582	0.0319	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.000582	0.0319	CbGpPWpGaD
Methyclothiazide—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.000509	0.0229	CcSEcCtD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.000486	0.0266	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.000452	0.0248	CbGpPWpGaD
Methyclothiazide—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.000445	0.02	CcSEcCtD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.000441	0.0242	CbGpPWpGaD
Methyclothiazide—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.000423	0.019	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00042	0.0189	CcSEcCtD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00041	0.0225	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.000403	0.0221	CbGpPWpGaD
Methyclothiazide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000387	0.0174	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.000367	0.0165	CcSEcCtD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.000366	0.0201	CbGpPWpGaD
Methyclothiazide—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.000341	0.0153	CcSEcCtD
Methyclothiazide—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.000335	0.0151	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000332	0.0149	CcSEcCtD
Methyclothiazide—SLC12A3—nephron tubule—nephrolithiasis	0.000326	0.0133	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000313	0.0172	CbGpPWpGaD
Methyclothiazide—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000311	0.014	CcSEcCtD
Methyclothiazide—SLC12A3—renal system—nephrolithiasis	0.000296	0.0121	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000287	0.0157	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000287	0.0157	CbGpPWpGaD
Methyclothiazide—SLC12A3—kidney—nephrolithiasis	0.000286	0.0117	CbGeAlD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000285	0.0156	CbGpPWpGaD
Methyclothiazide—SLC12A3—cortex of kidney—nephrolithiasis	0.000279	0.0114	CbGeAlD
Methyclothiazide—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000273	0.0123	CcSEcCtD
Methyclothiazide—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00027	0.0121	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00026	0.0143	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00026	0.0143	CbGpPWpGaD
Methyclothiazide—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.000254	0.0114	CcSEcCtD
Methyclothiazide—SLC12A1—nephron tubule—nephrolithiasis	0.000249	0.0101	CbGeAlD
Methyclothiazide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000236	0.0106	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000233	0.0105	CcSEcCtD
Methyclothiazide—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000232	0.0104	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000229	0.0103	CcSEcCtD
Methyclothiazide—SLC12A1—renal system—nephrolithiasis	0.000226	0.00922	CbGeAlD
Methyclothiazide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000225	0.0101	CcSEcCtD
Methyclothiazide—SLC12A1—kidney—nephrolithiasis	0.000219	0.00891	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000217	0.0119	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000217	0.0119	CbGpPWpGaD
Methyclothiazide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000215	0.00969	CcSEcCtD
Methyclothiazide—SLC12A1—cortex of kidney—nephrolithiasis	0.000213	0.00868	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000202	0.0111	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000202	0.0111	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000197	0.0108	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000197	0.0108	CbGpPWpGaD
Methyclothiazide—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000196	0.00881	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000183	0.0101	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000183	0.0101	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00018	0.00987	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000179	0.0098	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000179	0.0098	CbGpPWpGaD
Methyclothiazide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000173	0.0078	CcSEcCtD
Methyclothiazide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00017	0.00765	CcSEcCtD
Methyclothiazide—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000166	0.00746	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000163	0.00896	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000162	0.00889	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000162	0.00889	CbGpPWpGaD
Methyclothiazide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000162	0.00729	CcSEcCtD
Methyclothiazide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000161	0.00726	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000159	0.00873	CbGpPWpGaD
Methyclothiazide—CA1—renal system—nephrolithiasis	0.000156	0.00634	CbGeAlD
Methyclothiazide—CA1—kidney—nephrolithiasis	0.00015	0.00613	CbGeAlD
Methyclothiazide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000147	0.00662	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000146	0.00799	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000146	0.00799	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000145	0.00793	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000144	0.00648	CcSEcCtD
Methyclothiazide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00014	0.00631	CcSEcCtD
Methyclothiazide—CA4—nephron tubule—nephrolithiasis	0.000134	0.00545	CbGeAlD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000132	0.00725	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000132	0.00725	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000132	0.00595	CcSEcCtD
Methyclothiazide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000128	0.00576	CcSEcCtD
Methyclothiazide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000126	0.00566	CcSEcCtD
Methyclothiazide—CA4—renal system—nephrolithiasis	0.000122	0.00496	CbGeAlD
Methyclothiazide—CA4—kidney—nephrolithiasis	0.000118	0.00479	CbGeAlD
Methyclothiazide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000117	0.00526	CcSEcCtD
Methyclothiazide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000116	0.00524	CcSEcCtD
Methyclothiazide—CA4—cortex of kidney—nephrolithiasis	0.000115	0.00467	CbGeAlD
Methyclothiazide—CA2—nephron tubule—nephrolithiasis	0.000111	0.00452	CbGeAlD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00011	0.00605	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00011	0.00605	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000108	0.00488	CcSEcCtD
Methyclothiazide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000106	0.00475	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000103	0.00563	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000103	0.00563	CbGpPWpGaD
Methyclothiazide—CA2—renal system—nephrolithiasis	0.000101	0.00411	CbGeAlD
Methyclothiazide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000101	0.00453	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0001	0.0055	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0001	0.0055	CbGpPWpGaD
Methyclothiazide—CA2—kidney—nephrolithiasis	9.75e-05	0.00397	CbGeAlD
Methyclothiazide—Dizziness—Hydrochlorothiazide—nephrolithiasis	9.73e-05	0.00438	CcSEcCtD
Methyclothiazide—CA2—cortex of kidney—nephrolithiasis	9.5e-05	0.00387	CbGeAlD
Methyclothiazide—Vomiting—Hydrochlorothiazide—nephrolithiasis	9.36e-05	0.00421	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	9.32e-05	0.00511	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	9.32e-05	0.00511	CbGpPWpGaD
Methyclothiazide—Rash—Hydrochlorothiazide—nephrolithiasis	9.28e-05	0.00418	CcSEcCtD
Methyclothiazide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	9.27e-05	0.00417	CcSEcCtD
Methyclothiazide—Headache—Hydrochlorothiazide—nephrolithiasis	9.22e-05	0.00415	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	9.14e-05	0.00501	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	9.14e-05	0.00501	CbGpPWpGaD
Methyclothiazide—Nausea—Hydrochlorothiazide—nephrolithiasis	8.74e-05	0.00393	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.3e-05	0.00455	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.3e-05	0.00455	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	7.31e-05	0.00401	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	6.64e-05	0.00364	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GRHPR—nephrolithiasis	4.97e-05	0.00272	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GRHPR—nephrolithiasis	4.76e-05	0.00261	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GRHPR—nephrolithiasis	4.57e-05	0.0025	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AGXT—nephrolithiasis	4.43e-05	0.00243	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AGXT—nephrolithiasis	4.24e-05	0.00233	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AGXT—nephrolithiasis	4.07e-05	0.00223	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC26A1—nephrolithiasis	3.76e-05	0.00206	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—APRT—nephrolithiasis	3.76e-05	0.00206	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—APRT—nephrolithiasis	3.61e-05	0.00198	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC26A1—nephrolithiasis	3.61e-05	0.00198	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—APRT—nephrolithiasis	3.46e-05	0.0019	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC26A1—nephrolithiasis	3.46e-05	0.0019	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AQP1—nephrolithiasis	2.68e-05	0.00147	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AQP1—nephrolithiasis	2.57e-05	0.00141	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AQP1—nephrolithiasis	2.47e-05	0.00135	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CHRM3—nephrolithiasis	2.43e-05	0.00133	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CHRM3—nephrolithiasis	2.33e-05	0.00128	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CHRM3—nephrolithiasis	2.23e-05	0.00122	CbGpPWpGaD
